Sabine Steffens

Sabine Steffens works in Preventive Cardiology affiliated with Helmholtz Zentrum München.

Sabine Steffens is a W2 Professor of Clinical Pathobiochemistry at the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, and an Associated Group Leader in Cardiovascular Disease Comorbidities at the Institute for Diabetes and Cancer, Helmholtz Munich. Her research investigates the role of endogenous lipid signaling pathways in inflammatory processes underlying atherosclerosis and adverse cardiac remodeling. She previously served as a postdoc and junior group leader at the Medical Faculty of Geneva from 2003 to 2013.